Shashi Shankar
About
Detail
CEO, Founder
New York, United States
Résumé
Jobs
verified_user
0% verified
Chief Executive Officer, FounderNovelliaJan 2023 - Current (3 years 6 months)Building the single source of truth for patient health data, powered by AI. We give patients full control of their health journeys and power faster therapeutic innovation for the world's top biopharmas. Data published at ASCO, SABCS, AACR, etc. Named 2025’s most innovative EHR by MedTech and a Top 10 Digital Health Startup by DHNY. Backed by the investors behind OpenAI, Palantir, Guardant, Color Genomics, and more.- ExplorerSabbaticalApr 2022 - Dec 2022 (9 months)Hiked a bunch, traveled a lot, began a lifelong meditation practice, and planted the (pre)seed for what ultimately became Novellia.
- Global Commercial Lead, Digital HealthRocheOct 2021 - Mar 2022 (6 months)Global commercial lead @ Roche digital health. See past experience for more info.
- Global Launch & Marketing, Digital HealthRocheMar 2020 - Oct 2021 (1 year 8 months)Recruited by Roche global HQ to help design our worldwide digital health strategy. One exciting highlight from this time: amidst a global pandemic, our team successfully nailed the international launch, regulatory approval, and marketing of Genentech/Roche's first digital health product. Rapidly scaled from proof-of-concept to an FDA-cleared + CE-marked globally adopted in-clinic solution.
- Senior Product ManagerGenentechMay 2019 - Mar 2020 (11 months)Oversaw key marketing efforts for one of Genentech's largest portfolios (+$2bn), covering therapies across oncology, transplant, and respiratory.
- Special Executive Assignment: Real World Data x Personalized HealthcareGenentechApr 2019 - Mar 2020 (1 year)Special assignment from Genentech/Roche c-suite. Established a real world data / personalized healthcare partnership between a Top-5 ranked cancer center, Genentech, Flatiron Health, Foundation Medicine, and an undisclosed healthtech.
- Medical Affairs Senior ManagerGenentechOct 2017 - May 2019 (1 year 8 months)Launched OCREVUS, #1 prescribed MS medicine in the world, >$20b in revenue.
- Medical Affairs ManagerGenentechJan 2016 - Dec 2017 (2 years)Worked on Genentech's blockbuster oncology portfolio (Rituxan, Herceptin, Perjeta). Accelerated promotion within a year.
- AssociateCAQHJan 2014 - Dec 2016 (3 years)K-street associate working with the nation's major insurers (CMS, UnitedHealthcare, Aetna, etc.) following passage of PPACA (Obamacare) to bring standardization to health insurance. Savings of $9.5b and $5.8b delivered to US payers and providers, respectively.
- Senior AnalystAdvisory BoardJan 2013 - Dec 2014 (2 years)Strategy consultant to the C-suites of America's top hospitals. Did some fun benchmark modeling, financial forecasting, and claims data analysis.
- Health Economist (HEOR Intern)GenentechJan 2013 - Dec 2013 (1 year)Accepted into highly-competitive Genentech Summer Intern program (<8% acceptance rate) to support pre-launch activities. Received full-time return offer.
- Marketing InternBruker BioSpinJan 2012 - Dec 2012 (1 year)Market data analyst at the world's #1 NMR/MRI manufacturer.
- Research InternTufts Medical CenterMay 2011 - Aug 2011 (4 months)• Lab research: Studied melanomal mouse models to investigate p19 and dysregulation of cancer cells; focused specifically on cancer cell function in the G1 phase of the cell cycle • Data management: Documented lab research data and analyzed new treatment opportunities for targeted areas of oncology research using Western Blot, PCR, and chromatography analyses
- Clinical Research InternActivMed Practices Research LLCMay 2010 - Aug 2010 (4 months)
Education
verified_user
0% verified
- Global Commercial Strategy (Executive Education, International BusinessINSEADJan 2020 - Dec 2020 (1 year)A global approach to digital health and pharma marketing in an agile world. Specific focus on launching and building strong global brands and transforming the customer experience through meaningful value creation and harnessing the power of data analytics and market intelligence.
- Master of Business Administration - MBA, (Carey Scholar) Corporate Strategy, Marketing, Consumer BehaviorThe Johns Hopkins UniversityReceived the prestigious merit-based Carey scholarship.
- Master of Public Health (MPH, Healthcare Management, Health PolicyDartmouth CollegeStudied the intersection of healthcare and business at Dartmouth's Geisel School of Medicine and the Tuck School of Business under the mentorship of the nation's leading experts on public health, epidemiology, and the life sciences business. Received offers from top firms across consulting and industry based on excellent academic record. Key Courses: Business of Healthcare (Tuck School of Business), Strategic and Financial Management of Health Systems, Health Institution Quality Improvement, Patient Safety- Reducing Medical Errors, Epidemiology, Biostatistics. Research Capstone: Evaluating the Impact of Racial Discordance Among Diabetic Patients: Designing A Randomized Controlled Trial
- Bachelor of Science (BS, (Howard Hughes Scholar) English, Chemistry, PhysicsBates CollegeA pre-med English major who fused a love for communication and story-telling with a lifelong passion for science and analytics. Received a Howard Hughes Medical Scholarship, and spent my free-time interning at Mass Gen and conducting cell research at Tufts. Also...produced a hip-hop album as my senior independent study.
Awards
verified_user
0% verified
- Genentech Oncology Innovation AwardGenentechJan 2020Personalized healthcare team recognized for extraordinary contributions to Genentech/Roche’s US oncology strategy. Team developed and executed novel partnership strategy between Genentech and largest oncology institutions across the country, redefining industry-clinician relationship and advancing oncology care for patients on a national level.
- Genentech Odyssey Leadership ProgramRocheJan 2020Rigorous six month leadership development program where ~30 high potential Genentech employees (0.002% of workforce) are handpicked by senior leaders to work 1:1 with a leadership coach and work across a cross-functional team to propose solutions to pressing business needs.
- 2019 Genentech Marketers Award for PurposeRocheDec 2019Received the franchise's top marketing award for purpose for leading a team in establishing a customer engagement framework for a $2bn portfolio.
- 2019 Roche Global Agile AwardRocheNov 2019Work done leading team in developing customer engagement strategy selected as Roche's 2019 Global Impact on Agility winner. Demonstrates excellence in thriving in ambiguous environments, and living the agile ways of working.
- GGenentech Emerging ManagerGenentech IncMay 2018Nominated by senior leaders; completed highly selective corporate development training program with pathway into formal leadership role.
- 2017 Roche Global Best Practice AwardRocheJan 2017Pioneering work in multiple sclerosis shared decision-making strategy selected as 2017 Roche Best Practice, from across all affiliates worldwide.
Publications
verified_user
0% verified
- AIMPACT-NSCLC: Innovative machine-learning protocols for accurate clinical biomarker testing in non-small cell lung canceAmerican Society of Clinical OncologySep 2024
- Preferences, Needs and Opportunity Areas for US Multiple Sclerosis CaregiversGenentechMay 2019Lead author on a first-ever research project examining the needs of caregivers for people living with multiple sclerosis in the United States, and ways in which to meet these needs. Contributed significantly to an expanding body of work in MS around patient engagement, care partner research, and shared decision-making.
- EImpact of shared decision making on improving patient-clinician interactions and ms quality measures: a pilot studyEuropean Committee for Treatment and Research in Multiple Sclerosis ECTRIMSOct 2018A pilot study in MS that demonstrated shared decision-making education and training may effectively improve patient-clinician collaboration and enhance the patient experience in MS.
- Payer & Provider Interoperability: Claims, Benefit Enrollment, Premiums (Phase IV Operating Rules)CAQHJan 2016Large, cross-collaborative work on federally mandated interoperability rules that drive efficiency between payers and providers surrounding health care claims, benefit enrollment, and premium payment.
- Implementation Guide: Health Care Claims, Benefit Enrollment, Premium PaymentCAQHJan 2016Project lead on Phase IV CAQH CORE Operating Rules Analysis & Planning Guide.
- SWhat you need to know about MitraClip's CMS coverage decisionShashi Shankar Advisory Board CompanyJul 2014In-depth review on key points of CMS’s coverage decision on blockbuster mitral valve repair therapy device and predictive report on potential future impacts of device adoption.
- SBecoming a Foundation Trust: From Application to SustainabilityShashi Shankar Advisory Board CompanyJul 2014Lead consultant on white paper guide for UK hospitals navigating transition to Foundation Trust status. White paper utilizes literature review and extensive interviews with international SMEs and C-suite leadership over six-month period to identify organisational, clinical, and strategic best practices to achieve NHS authorisation and ensure continued success.
- SHow to Prepare for Outpatient EVARShashi Shankar Advisory Board CompanyMar 2014Brief strategic primer for hospital CV programs regarding consequences of the shift in endovascular aortic repair (EVAR) to outpatient setting amidst industry transition to value-based care.
- SDevelopments in Vascular Interventions Aren't Slowing DownShashi Shankar Advisory Board CompanyJan 2014Report on medical device outlook for 2014 in the cardiovascular space; includes review of clinical trials, impact of FDA regulation on future device roll-out, and discussion of leveraging new device opportunities to better utilize hospital resources (reduce readmission rate, decrease cost of care, minimize complicate rate, etc).